- Summits
- Sponsorship
- Media Opportunities
- News
- About
Day 1 of MedTech World Middle East | Dubai 2026 delivered a full programme of discussion, company showcases, and high-level networking, setting a strong tone for the day ahead.
From the moment doors opened, the venue was alive with conversations around regulation, investment, cross-border expansion, and the realities of commercialising innovation in today’s healthcare systems. Founders, investors, clinicians, and industry leaders moved between panels and meetings, continuing discussions well beyond the stage.
The conference agenda brought together diverse perspectives across the MedTech ecosystem. Panels explored how companies can move from early development to scalable operations, how to navigate regional market access, and how capital is being deployed across emerging sectors including neurotechnology.
Alongside the discussions, company showcases spotlighted innovative solutions shaping different corners of healthcare.
Leucadia Therapeutics, Adtec Healthcare Limited, and DNeuro Biosciences each took to the stage to present their work, drawing interest from investors and strategic partners in the room. The sessions sparked follow-up meetings almost immediately, as attendees sought deeper conversations on science, strategy, and collaboration.
Dr. Tahir Yahya, VP Medical/Clinical Affairs at DNeuro Biosciences, reflected on the energy throughout the day:
“It was a great turnout. I ran into quite a few people interested in what we’re doing in the space and a lot of good discussions around what this could mean for the region and also some collaboration. And there was a lot of opportunity for synergy to work with some of these individuals from Europe and Middle East.”
His comments echoed what many participants experienced: a programme designed not just for listening, but for engaging.
Midday, conversations continued over a luncheon sponsored by Blue Goat Cyber and CS Lifesciences, titled “Scaling or Stalling: Who Actually Wins in Global MedTech?”
The session examined what truly separates companies that scale internationally from those that struggle to move beyond early traction. Speakers and participants discussed capital efficiency, regulatory preparedness, cybersecurity considerations, and the importance of choosing the right partners at the right time.
Rather than abstract theory, the discussion centred on lived experience, what has worked, what has failed, and where companies often underestimate complexity when expanding across borders.
The luncheon format allowed for candid exchanges, with attendees challenging each other’s assumptions and sharing practical lessons from both mature and emerging markets.
Throughout the day, a dedicated space was set aside for one-to-one meetings, facilitated by the MedTech World Match app. Many participants arrived in Dubai with pre-scheduled meetings already confirmed through the platform, while others arranged conversations on the spot.
The result was a steady flow of focused discussions: investor-founder introductions, partnership explorations, advisory conversations, and early-stage dealmaking. The structured meeting area ensured that connections moved beyond quick introductions to meaningful dialogue.
For many, this was where the real work happened: translating stage insights into tangible next steps.
Varun Turlapati, Managing Director at Chaanakya Capital, shared his experience:
“I met some exciting founders as well as some energetic other fund managers who were talking to me about deal making. Some ideas are not only for current deals but also for the future. In addition, we are already in talks about how we can add value mutually in the next upcoming events with MedTech World.
The most prominent one that we are thinking about is being in Florida. With exciting sectors like Neurotech within even the MedTech space and exciting venues, I think there’s a lot to look forward to. And I already have a lot of homework to do.”
His remarks underscored the cross-event continuity that MedTech World fosters, with conversations in Dubai already extending toward MedTech World North America in Florida.
As the formal programme concluded, the energy shifted to a more relaxed yet equally purposeful setting. The VIP Evening Reception, proudly sponsored by Blue Goat Cyber and co-hosted by Verge HealthTech Fund, brought together Platinum ticket holders for an intimate, high-level networking experience.
Hosted at Zaytoun, Crowne Plaza Dubai Festival City, the reception offered curated conversations, premium hospitality, and direct access to key decision-makers across investment, industry, and clinical leadership.
With the Dubai skyline as a backdrop, discussions continued into the evening—partnerships explored, follow-ups planned, and new introductions made in a setting designed to encourage openness and depth.
Day 1 of MedTech World Middle East | Dubai 2026 demonstrated the strength of gathering global stakeholders in one room, where discussions are practical, introductions are intentional, and momentum builds quickly.
As Day 1 concludes, anticipation is building for one of the most awaited moments of the event — the MedTech World Startup Pitch Competition. If the first day is any indication, the conversations started here will continue well beyond Dubai, shaping collaborations and initiatives across regions in the months ahead.
As conversations continue into Day 2, many are already looking ahead to the next chapter. MedTech World North America will take place in Florida, USA, from 11 to 13 May 2026, bringing together founders, investors, and healthcare leaders for another focused programme of insight and connection. If Dubai has shown anything, it’s that the right room can accelerate the right conversations. Secure your place and be part of what’s next.
